Correlation between mean thrombocyte volume and microalbuminuria in type 2 diabetes mellitus patients
DOI:
https://doi.org/10.18203/2320-6012.ijrms20253961Keywords:
Correlation, Diabetes mellitus, HbA1c, Mean thrombocyte volume, MicroalbuminuriaAbstract
Background: The determination of microalbuminuria is beneficial in detecting cases of type 2 diabetes mellitus (T2DM), which can result in renal and cardiovascular diseases. A few studies correlating mean thrombocyte volume (MTV) with microalbuminuria have shown positive results; however, data remain limited in the Indian population. The present study evaluated the association between MTV and microalbuminuria in patients with (T2DM).
Methods: This hospital-based cross-sectional study was conducted from February 2023 to January 2024 in Maharashtra, India. Sixty patients of either sex, aged 18 years or older, with a duration of T2DM greater than four years and diagnosed according to American Diabetes Association criteria, were included. The duration of diabetes mellitus (DM), HbA1c, and urine microalbumin were noted. The primary objective was to determine the relationship between MTV and microalbuminuria, while the secondary objectives were to assess the associations between MTV and the duration of T2DM and between MTV and HbA1c. The sample size was statistically powered to detect a significant correlation between MTV and microalbuminuria, aligning with findings from prior research.
Results: The mean MTV was significantly elevated in patients with a duration of diabetes greater than ten years, HbA1c >7%, and urine microalbumin levels >30 mg/g. A significant positive correlation of 0.936, 0.552, 0.875 and 0.433 was observed between MTV and urine microalbumin levels, the duration of DM, HbA1c and age, respectively.
Conclusions: MTV serves as a simple and cost-effective marker for assessing glycemic control and early detection of renal involvement in T2DM. The study reinforces the potential role of MTV as a supportive tool for monitoring disease progression and guiding preventive care in diabetic patients.
Metrics
References
Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004;27(5):1047-53. DOI: https://doi.org/10.2337/diacare.27.5.1047
Bahia LR, Araujo DV, Schaan BD, Dib SA, Negrato CA, Leão MP, et al The costs of type 2 diabetes mellitus outpatient care in the Brazilian public health system. Value Health. 2011;14(5):S137-40. DOI: https://doi.org/10.1016/j.jval.2011.05.009
Matheus AS, Tannus LR, Cobas RA, Palma CC, Negrato CA, Gomes MB. Impact of diabetes on cardiovascular disease: an update. Int J Hypertens. 2013;2013:653789. DOI: https://doi.org/10.1155/2013/653789
Orasanu G, Plutzky J. The pathologic continuum of diabetic vascular disease. J Am Coll Cardiol. 2009;53(5):S35-42. DOI: https://doi.org/10.1016/j.jacc.2008.09.055
Carr ME. Diabetes mellitus: a hypercoagulable state. J Diabetes Complications. 2001;15(1):44-5. DOI: https://doi.org/10.1016/S1056-8727(00)00132-X
Mandal S, Sarode R, Dash S, Dash RJ. Hyperaggregation of platelets detected by whole blood platelet aggregometry in newly diagnosed noninsulin-dependent diabetes mellitus. Am J Clin Pathol. 1993;100(2):103-7. DOI: https://doi.org/10.1093/ajcp/100.2.103
Vizioli L, Muscari S, Muscari A. The relationship of mean platelet volume with the risk and prognosis of cardiovascular diseases. Int J Clin Pract. 2009;63(10):1509-15. DOI: https://doi.org/10.1111/j.1742-1241.2009.02070.x
Papanas N, Symeonidis G, Maltezos E, Mavridis G, Karavageli E, Vosnakidis T, et al. Mean platelet volume in patients with type 2 diabetes mellitus. Platelets. 200415(8):475-8. DOI: https://doi.org/10.1080/0953710042000267707
Han JY, Choi DH, Choi SW, Kim BB, Ki YJ, Chung JW, et al. Stroke or coronary artery disease prediction from mean platelet volume in patients with type 2 diabetes mellitus. Platelets. 2013;24(5):401-6. DOI: https://doi.org/10.3109/09537104.2012.710858
Lekston A, Hudzik B, Hawranek M, Szkodzinski J, Gorol J, Wilczek K, et al. Prognostic significance of mean platelet volume in diabetic patients with ST-elevation myocardial infarction. J Diabetes Complications. 2014 ;28(5):652-7. DOI: https://doi.org/10.1016/j.jdiacomp.2014.05.002
Garg JP, Bakris GL. Microalbuminuria: Marker of vascular dysfunction, risk factor for cardiovascular disease. Vasc Med. 2002;7(1):35-43. DOI: https://doi.org/10.1191/1358863x02vm412ra
Jager A, van Hinsbergh VW, Kostense PJ, Emeis JJ, Nijpels G, Dekker JM, et al. C-reactive protein and soluble vascular cell adhesion molecule-1 are associated with elevated urinary albumin excretion but do not explain its link with cardiovascular risk. Arterioscler Thromb Vasc Biol. 2002;22(4):593-8. DOI: https://doi.org/10.1161/01.ATV.0000013786.80104.D4
Klausen K, Borch-Johnsen K, Feldt-Rasmussen B, Jensen G, Clausen P, Scharling H, et al. Very low levels of microalbuminuria are associated with increased risk of coronary heart disease and death independently of renal function, hypertension, and diabetes. Circulation. 2004;110(1):32-5. DOI: https://doi.org/10.1161/01.CIR.0000133312.96477.48
Razak MKA, Akif AM, Nakeeb N, Rasheed JI. The relationship between mean platelet volume and albuminuria in patients with type 2 diabetes mellitus. Diabetes Metab Syndr. 2019;13(4):2633-9. DOI: https://doi.org/10.1016/j.dsx.2019.07.021
Brahmbhatt KJ, Chaudhary B, Raval DM, Mallik S, Khan S, Patel M, et al. Association of Mean Platelet Volume With Vascular Complications in the Patients With Type 2 Diabetes Mellitus. Cureus. 2022;14(9):e29316. DOI: https://doi.org/10.7759/cureus.29316
ElSayed NA, Aleppo G, Aroda VR, Bannuru RR, Brown FM, Bruemmer D, et al. 2. Classification and Diagnosis of Diabetes: Standards of Care in Diabetes-2023. Diabetes Care. 2023;46(1):S19-40. DOI: https://doi.org/10.2337/dc23-S002
Hulley SB, Cummings SR, Browner WS, Grady D, Newman TB. Designing clinical research: an epidemiologic approach. 4th edition. Philadelphia, PA: Lippincott Williams & Wilkins. 2013.
Khanna P, Salwan SK, Sharma A. Correlation of Platelet Indices in Patients With Type 2 Diabetes Mellitus and Associated Microvascular Complications: A Hospital-Based, Prospective, Case-Control Study. Cureus. 2024;16(3):e55959. DOI: https://doi.org/10.7759/cureus.55959
Alzahrani AM, Alesa AA, Yaghmour AE, Khan MA, Alesa AA. The Association between Mean Platelet Volume and Albuminuria in Patients with Type 2 Diabetes Mellitus at King Abdul-Aziz Medical City, Jeddah 2020. Arch Clin Biomed Res. 2021;5:702-13. DOI: https://doi.org/10.26502/acbr.50170195
Bhattarai T, Pandey A, Parajuli S, Khanal P, Dongol A, Devkota R, et al. Microalbuminuria among Patients with Diabetes Mellitus Visiting the Department of Nephrology in a Tertiary Care Centre: A Descriptive Cross-sectional Study. J Nepal Med Assoc. 2023;61(263):596-8. DOI: https://doi.org/10.31729/jnma.8214
Joena V, Prabhuswamy KM. Association between mean platelet volume and Microalbuminuria in Type 2 Diabetes Mellitus Patients. Int J Med Res Rev. 2017;5(3):331-7. DOI: https://doi.org/10.17511/ijmrr.2017.i03.19
Ünübol M, Ayhan M, Güney E. The relationship between mean platelet volume with microalbuminuria and glycemic control in patients with type II diabetes mellitus. Platelets. 2012;23(6):475-8. DOI: https://doi.org/10.3109/09537104.2011.634934
Demirtunc R, Duman D, Basar M, Bilgi M, Teomete M, Garip T. The relationship between glycemic control and platelet activity in type 2 diabetes mellitus. J Diab Compl. 2009;23(2):89-94. DOI: https://doi.org/10.1016/j.jdiacomp.2008.01.006
Downloads
Published
How to Cite
Issue
Section
